Neurotez

Neurotez Inc. is developing a drug to treat Leptin deficiency in Alzheimer’s patients.

Overview

Raised to Date: Raised: $15,952

Total Commitments ($USD)

Platform

Netcapital

Start Date

09/01/2022

Close Date

01/27/2023

Min. Goal

$10,000

Max. Goal

$500,000

Min. Investment

$100

Security Type

Equity - Common

Series

Seed

Funding Type

RegCF

Price Per Share

$4.00

Pre-Money Valuation

$45,272,228

Rolling Commitments ($USD)

Status
Funded
Reporting Date

01/31/2023

Days Remaining
Funded
% of Min. Goal

160%

% of Max. Goal

3%

Likelihood of Max
Funded
Avg. Daily Raise

$108

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

Bridgewater, New Jersey

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

Neurotez, with a valuation of $45.2 million, is raising funds on NetCapital. The company is developing a hormone replacement therapy named Memtin to treat Leptin deficiency in Alzheimer’s patients. The drug will help slow down cognitive decline in patients with Alzheimer’s and other forms of dementia. Neurotez has already received many rewards and recognitions and is backed by an excellent team of experts. Nikolaos Tezapsidis founded Neurotez in 2005. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $500,000. The campaign proceeds will be used for research and development, marketing, compensation for managers, and legal expenses.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$3,184

$1,250

 

 

Net Income

$-314,585

$-188,407

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$24,783

$5,882

Accounts Receivable

$0

$0

Total Assets

$169,799

$164,744

Short-Term Debt

$0

$65,356

Long-Term Debt

$62,255

$0

Total Liabilities

$62,255

$65,356

Financials as of: 09/01/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Neurotez 01/27/2023 Netcapital $45,272,228 $15,952 Equity - Common Funded RegCF
Neurotez 03/10/2022 StartEngine $44,870,036 $33,845 Equity - Common Funded RegCF
Neurotez 06/24/2021 Netcapital $21,959,058 $255,718 Equity - Common Funded RegCF
Neurotez 02/26/2018 Netcapital $24,544,690 $95,809 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Analyst Report Analyst Report Methodology Article

Pending Review

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Neurotez on NetCapital 2022
$
Platform: Netcapital
Security Type: Equity - Common
Valuation: $45,272,228
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Neurotez on NetCapital 2022
View on Netcapital (Closed)